Effectiveness of radiation therapy for older women with early breast cancer

	Tweet

Elderly women with early-stage breast cancer had a lower risk of recurrence when they were treated with radiation therapy, according to a study in the Journal of the National Cancer Institute.

A clinical trial in 2004 by the Cancer and Leukemia Group B (trial C9343) investigated whether radiation therapy is an effective way to decrease risk of breast cancer recurrence in women 70 years and older with estrogen receptor (ER) positive, early-stage breast cancer. Based on the results of the study, new clinical guidelines suggested that radiation therapy may not be necessary for these women, because of the small benefit, high cost, and side effects of radiation therapy.

In this issue of the journal, Benjamin D. Smith, M.D., of Yale School of Medicine in New Haven, CT, and colleagues identified 8,724 women over age 70 years who underwent surgery for ER-positive, early-stage breast cancer. They examined whether patients who received radiation therapy had a lower risk of recurrence and subsequent mastectomy, and they also tried to identify patients who were most likely to benefit from radiation therapy.

The authors found that radiation therapy was associated with a reduced risk of breast cancer recurrence and the number of subsequent mastectomies. Patients aged 70-79 years who were in good health gained the greatest benefit from radiation therapy. Patients aged 80 years or older with moderate or high levels of other illness gained less benefit from radiation therapy.

The authors conclude, “Our results indicate that important, readily identifiable characteristics can determine which patients are most likely to benefit from radiation therapy.”

In an accompanying editorial, Bruce E. Hillner, M.D., from Virginia Commonwealth University in Richmond, Va., and Jeanne Mandelblatt, M.D., from Georgetown University Medical Center in Washington, D.C., compliment Smith and colleagues on a well-designed study with “critical” findings. They write, “High-quality observational studies such as that by Smith et al. can be used to provide information for clinical and policy decision-making for the rapidly growing older population of women at risk for breast cancer. These data could also be used to provide information for shared decision-making between older women and their providers.”

http://jncicancerspectrum.oupjournals.org

RELATED STORIES:
Sisters of women with breast cancer joining study   FISH Technology Preferred for Choosing HER-2-Positive Breast Cancer Treatments   New studies on surgical options in inherited breast cancer show drastic treatment is not always best   MRI cost-effective for some women at high-risk of breast cancer   New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks   UK breast screening information has serious shortcomings   Cancer publishes study confirming disparity in breast cancer treatment   Even women with a family history can control breast cancer risk   No long-term cancer risk seen from breast implants   Taking tamoxifen to prevent breast cancer can save lives and money   Targeted breast ultrasound can reduce biopsies for women under 40   Ethnic Variations in Hormone Levels May Cause Differences in Breast Cancer Risk   Drug May Combat Weight Loss During Radiation Treatments   2 new compounds show promise for eliminating breast cancer tumors   Lasers Illuminate Women’s Health in inaugural open-access journal Biomedical Optics Express   Well-educated women hardest hit by breast cancer   Breast cancer risk tied to grandmother’s diet   Tamoxifen resistance—and how to defeat it   Gene explains breast cancer chemotherapy outcomes   Stress Linked To How Aggressive A Breast Cancer Might Be   Simple fingertip test may identify breast cancer patients at risk for carpal tunnel syndrome   Cell Study Finds Receptor Can Fight Tamoxifen-resistant Breast Cancer Cells

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]